Meridian Agrees License Deal With Corixa

, Inc., will begin production of recombinant Trypanosoma cruzi (Chagas’ disease) antigen under a license agreement with . Manufacture will take place in its life science production laboratories located at , Inc., (VAI), a wholly owned subsidiary.

The unique recombinant polyvalent antigen, known as TcF, will be marketed to diagnostic test manufacturers for use in production of test kits for blood bank screening and other diagnostic applications.

T. cruzi causes Chagas’ disease, a chronic infection that primarily affects the nervous system and heart, causing severe neurological disorders, as well as swelling or denervation of nervous tissue in the heart, colon and esophagus.

Richard Eberly, General Manager, Meridian Life Science commented, “We are delighted that VAI’s original research and development agreement with Corixa has now resulted in a strategic partnership to make this important antigen available for commercialization partners. We are pleased that VAI will now make this antigen available to manufacturers worldwide for incorporation into test kits to improve the safety of the blood supply.”

David Persing, M.D., Ph.D., Vice President of Discovery Research at Corixa, said recently “In studies to date, the TcF recombinant antigen has been able to detect specific antibodies in nearly all patients infected with T. cruzi, and avoids many of the problems of false positivity and unreliability associated with older assays that used whole organisms for antibody detection. Testing for this antibody could be an important step toward protecting our nation’s blood supply from this dangerous contaminant.”

Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and

Shop Steroids

Dragon Pharma is manufacturing a large range of steroids Order Oxymetholon on Sale.

Buy Dragon Pharma Steroids

Dragon Pharma is manufacturing a wide range of steroids Legal Winstrol 50mg.

Buying Dragon Pharma LLC Safely


Beta-2 Agonist, Bronchodilator
Basal Chemical Name: Clenbuterol Hydrochloride
Produced by: Dragon Pharmaceuticals
Unit: 1 X 100 tabs (40 mcg/tablet)

Oxymetholon - Discount Price

Administration: Oral
Base Substance: Oxymetholone
Produced by: Dragon Pharma LLC
Package: 30 x 100 tablets (50 mg/tab)
Price: 30 x $51.00


Synthetic Anabolic Steroidal Agent
Prime Chemical Name: 4-Chlorodehydromethyltestosterone
Produced by: Dragon Pharmaceutical
Unit: 1 X 100 tablets (10 mg/pastille)

Clomid - Bulk Price

Administration: Oral
Prime Ingredient: Clomiphene Citrate
Branded by: Dragon Pharmaceuticals
Unit: 10 x 100 tabs (50 mg/pastille)
Price: 10 x $63.00

Trenbolone 100 - Bulk Price

Administration: Injection
Basic Substance: Trenbolone Acetate
Branded by: Dragon Pharma Labs
Pack: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $60.00

EQ 200 / Test E 200

Injectable Steroid for Muscle Growth
Mix of: Boldenone Undecylenate, Testosterone Enanthate
Branded by: Dragon Pharma
10 mL Sterile Multi-dose Vial (400 mg/mL)


Oral Steroid for Muscle Growth
Basal Constituent: Chlorodehydromethyltestosterone
Made by: Dragon Pharmaceuticals
100 tablets (20 mg/pill)

Trenbolone 200

Prime Substance: Trenbolone Enanthate
Produced by: Dragon Pharmaceuticals
Package: 10 x 10 mL vial (200 mg/mL)

Cut Mix 150

Prime Constituent: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Made by: Dragon Pharma
Unit: 10 mL vial (150 mg/mL)

Sustanon 350

Base Chemical Name: Testosterone Blend
Produced by: Dragon Pharmaceutical
Pack: 10 x 10 mL vial (350 mg/mL)

Deca 500

Active Ingredient: Nandrolone Decanoate
Produced by: Dragon Pharma Labs
Amount: 10 mL vial (500 mg/mL)

Winstrol 50

Prime Ingredient: Stanozolol
Produced by: Dragon Pharmaceutical
Package: 10 mL vial (50 mg/mL)